Document is current
Any future updates will be listed below
-
Authors
Qiao, Bo
Jin, Nenghao
Zhao, Min
Zhu, Liang
Li, Liangbo
Gu, Bin
Wen, Ning
Zhang, Haizhong
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (62471492)
- License Information
-
More Information
Article History
Received: 12 February 2024
Accepted: 3 September 2025
First Online: 8 October 2025
Declarations
:
: The studies involving human participants were reviewed and approved by Ethics Office of Chinese PLA General Hospital (Number: S2022-203-01). And the consent to participate in the study have been obtained from participants. Author confirm that all the experiments on the use of human tissue samples confirm that all experiment were performed in accordance with the Declaration of Helsinki’s guidelines and regulations.All animal experiments were conducted in accordance with the ARRIVE guidelines 2.0 (Animal Research: Reporting of In Vivo Experiments) and approved by the by the Ethics Committee for the Use of Animals of PLA General Hospital. (Approval No. 2021-X16-32, “LAMC2 promotes oral squamous cell carcinoma growth by activating the p-ERK/c-Myc signaling pathway” approved on Januray 5, 2021).
: Not applicable.
: The authors declare no competing interests.
